FAM26E functions as a voltage- and calcium-regulated ion channel with broad permeability to cations and signaling molecules like ATP . Key findings include:
Voltage gating: Activation at depolarized membrane potentials, modulated by extracellular Ca²⁺ ([Ca²⁺]₀) .
Ion selectivity: Poor discrimination among cations (e.g., Ca²⁺, Na⁺) and anions, enabling Ca²⁺ influx and ATP release .
Regulatory mechanism: Extracellular Ca²⁺ acts as an allosteric modulator, reducing channel open probability at physiological concentrations (~1.5 mM) .
Recombinant FAM26E is widely used for mechanistic studies and antibody validation. Key variants include:
Full-length constructs: Expressed in mammalian systems (e.g., HEK293) with tags (His, Fc-Avi) for purification .
Control fragments: Truncated proteins (e.g., aa 218–309) for blocking experiments in immunohistochemistry (IHC) and Western blotting (WB) .
| Expression System | Tag | Purity | Applications | Source |
|---|---|---|---|---|
| Mammalian Cells (HEK293) | His, Fc-Avi | >80% | Structural studies, assays | Creative BioMart |
| E. coli | His | >90% | Antibody validation | Thermo Fisher |
Cation channel activity: FAM26E interacts with TRPM1, ASIC3, and CALHM2/3 in cation transport pathways .
Pathway associations: Implicated in calcium signaling and neuronal excitability, though specific pathways remain under investigation .
Disease links: Polymorphisms in CALHM1 (a homolog) correlate with Alzheimer’s disease onset, suggesting potential neurodegenerative roles for CALHM5 .
Antibodies: Validated for WB, IHC, and flow cytometry (e.g., ABIN651998, ABIN1812617) .
Interacting proteins: Co-immunoprecipitation studies suggest associations with dynein and exocyst complex components .